292 related articles for article (PubMed ID: 24679952)
1. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
2. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
[TBL] [Abstract][Full Text] [Related]
3. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
4. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
6. Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
Fehringer G; Liu G; Pintilie M; Sykes J; Cheng D; Liu N; Chen Z; Seymour L; Der SD; Shepherd FA; Tsao MS; Hung RJ
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1097-104. PubMed ID: 22539604
[TBL] [Abstract][Full Text] [Related]
7. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
[TBL] [Abstract][Full Text] [Related]
8. The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.
de Mello RA; Ferreira M; Soares-Pires F; Costa S; Cunha J; Oliveira P; Hespanhol V; Reis RM
PLoS One; 2013; 8(9):e72373. PubMed ID: 24039754
[TBL] [Abstract][Full Text] [Related]
9. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
10. Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population.
Yadav S; Chandra A; Kumar A; Mittal B
Biochem Genet; 2018 Aug; 56(4):267-282. PubMed ID: 29450669
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
12. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
13. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema.
Wauters E; Smeets D; Coolen J; Verschakelen J; De Leyn P; Decramer M; Vansteenkiste J; Janssens W; Lambrechts D
Eur Respir J; 2011 Oct; 38(4):924-31. PubMed ID: 21622582
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract][Full Text] [Related]
17. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of Genetic Variation in Chromosome 5p15.33 and Telomere Length as Predictive and Prognostic Biomarkers for Lung Cancer.
Kachuri L; Latifovic L; Liu G; Hung RJ
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1537-1549. PubMed ID: 27566420
[TBL] [Abstract][Full Text] [Related]
20. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
